Onkos Surgical, Inc. appears in FDA records as an applicant for Class II orthopedic limb salvage devices under product code QZZ and regulation number 888.3900, described in the openFDA classification fields as a Limb And Joint Salvage Device With Coating For Bacteria Reduction. The supplied filings place the applicant at 77 East Halsey Road, Parsippany, New Jersey, an address used in FDA correspondence and recall records rather than a verified corporate headquarters. Two 510(k) records in the supplied sample carry a Substantially Equivalent decision, and two enforcement records describe Class II recalls of a personalized pelvic implant. The profile below stays with what those filings state about products, components and filing scope. [1][2][3]

Clearances in the supplied sample

K262286 covers the ELEOS™ with NanoCept® Technology Limb Salvage System, received July 6, 2026 and decided November 5, 2026 as Substantially Equivalent under a Traditional clearance type, with a summary statement and the Orthopedic advisory committee. K263628 covers the ELEOS™ Limb Salvage System with NanoCept® Technology (Proximal Tibia) (AM-25002200-C), received September 30, 2026 and decided October 29, 2026 as Substantially Equivalent under a Special clearance type. Both records list product code QZZ and regulation number 888.3900. [1][2]

The supplied collection counts two linked 510(k) records, both with a Substantially Equivalent decision, and the smaller record sample shows the same two decisions. These are counts of the supplied filings as of the snapshot date, not measures of total company portfolio, sales or safety performance. [1][2]

Documented components and coating scope

A company announcement dated November 6, 2026 states that a new 510(k) clearance extends NanoCept® Antibacterial Technology to additional titanium components of the ELEOS™ Limb Salvage System, naming proximal femurs, tibial baseplates and augments, and cemented bowed segmental stems. The announcement attributes the technology and clearance to Onkos Surgical. [7]

FDA correspondence for K252920, dated October 15, 2025, describes the ELEOS™ Limb Salvage System with NanoCept® Technology under regulation name Limb And Joint Salvage Device With Quaternary Ammonium Compound Coating, Class II, product codes QZZ and KRO. That letter states the modification expands the portfolio by adding a CoCr proximal tibia with MDPB coating and reports that no performance testing was conducted, with supporting information covering fretting and corrosion engineering analysis, coating integrity handling rationale and a biocompatibility risk assessment. [6]

The ELEOS™ and ELEOS™ with NanoCept® Technology Limb Salvage System instructions for use include an appendix listing femoral head compatibility part numbers and descriptions such as 28MM 15DG CROSSLINKED POLY LINER. A separate posted version of the same family of instructions carries an effective date of 05-DEC-2024 and reference ECN 24-019. [5][8]

Recall records for My3D implants

Two enforcement records, Z-0091-2027 and Z-0090-2027, identify Onkos Surgical, Inc. as the recalling firm for the My3D Personalized Pelvic Implant, Porous, Left, REF PV-ACREC-04M, each with a quantity of one implant and lot and case identifiers C26-0371 and C26-0346 respectively. Both are Class II, voluntary firm-initiated recalls with an ongoing status, initiated July 24, 2026 and classified October 6, 2026, with e-mail as the initial firm notification. [3][4]

The stated reason in both records is that personalized pelvic implants were inadvertently mixed up and distributed to incorrect customers, with distribution described as nationwide in North Carolina and California. The records document a device mix-up and distribution event; they do not establish clinical outcomes or broader product performance. [3][4]

Identity and documentation boundaries

The applicant name on the 510(k) records and the recalling firm name on the enforcement records match, and the Parsippany address appears across those filings. No parent company, brand ownership or corporate headquarters is verified in the public documents, so none is asserted here. [1][3]

Onkos Surgical's product documentation page lists instructions for use and surgical technique guides for the ELEOS™ Limb Salvage System, My3D® Personalized Pelvic Reconstruction, the JTS Extendible Prosthesis and Minimally Invasive Grower, and custom or compassionate devices. That listing shows which document sets the publisher posts; it does not confirm commercial availability or clinical performance of any listed device. [9]